ArticleJournal of cancer research and clinical oncology2009

Impact of angiotensin I converting enzyme inhibitors and angiotensin II type 1 receptor blockers on survival in patients with advanced non-small-cell lung cancer undergoing first-line platinum-based chemotherapy.

Stefan Wilop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.